These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8108814)

  • 1. [A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area].
    Bazhanov NN; Ganina SS; Ragimov ChR; Pashutin SB; Brusina LI
    Stomatologiia (Mosk); 1993; 72(4):22-5. PubMed ID: 8108814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of the efficacy of dalargin treatment in patients with face and neck phlegmons by the free-radical oxidation indices of the peripheral blood].
    Ganina SS; Ragimov ChR
    Stomatologiia (Mosk); 1991; (6):28-30. PubMed ID: 1803645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan].
    Zakson ML; Bordonos VG
    Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 8. [The experimental clinical substantiation of treatment of patients with odontogenic phlegmon of maxillofacial area using Dаlargin in complex therapy.].
    Platonova VV; Sevbitov AV; Shakaryants AA; Dorofeev AE
    Klin Lab Diagn; 2018; 63(5):293-296. PubMed ID: 30689324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The lymphocyte subpopulation in patients with duodenal ulcer and the immunocorrective activity of thymalin and dalargin].
    Lukash NV; Polishchuk TF; Ludan VV
    Lik Sprava; 1998 May; (3):56-8. PubMed ID: 9695565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use of thymalin in the prophylaxis and treatment of infectious-inflammatory diseases of the maxillofacial region].
    Solov'ev MM; Alekhova TM; Sysoeva EN; Morozov VG; Khavinson VKh
    Vestn Khir Im I I Grek; 1981 Dec; 127(12):6-11. PubMed ID: 7340043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of chlorhexidine effectiveness in treating acute inflammatory processes of the maxillofacial region].
    Gapanenko TG; Pecherkina SA; Kislykh FI; Dudin AB
    Stomatologiia (Mosk); 1983; 62(1):41-3. PubMed ID: 6572436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of leukinferon immunocorrection in patients with maxillofacial phlegmons].
    Tsymbalov OV; Nedel'ko NA; Kuznetsov VP; Beliaev DL
    Stomatologiia (Mosk); 2003; 82(6):23-6. PubMed ID: 14671589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Supersorbicid in comprehensive treatment of acute pyoinflammatory processes in maxillofacial region].
    Eshbadalov KhIu
    Stomatologiia (Mosk); 2005; 84(2):36-7. PubMed ID: 15798751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of quercetin granules for treating suppurative soft-tissue wounds of the maxillofacial area and neck].
    Timofeev AA; Maksiutina NP; Voĭtenko GN; Dobrovol'skiĭ IuN
    Stomatologiia (Mosk); 1989; 68(6):11-3. PubMed ID: 2623676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The possibilities of using clinical blood analysis for the prognosis of the course of acute suppurative inflammatory processes in the soft tissues of the maxillofacial area].
    Kurakin AV; Kuznetsova OI; Meshcheriakov DG
    Stomatologiia (Mosk); 1991; 70(1):35-7. PubMed ID: 2057948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
    Ragimov ChR
    Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
    Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
    Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
    [No Abstract]   [Full Text] [Related]  

  • 19. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.